Stem loop binding protein promotes SARS-CoV-2 replication via -1 programmed ribosomal frameshifting.

Journal: Signal transduction and targeted therapy
Published Date:

Abstract

The -1 programmed ribosomal frameshifting (-1 PRF) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for keeping the balance between pp1a and pp1ab polyproteins. To date, the host factors influencing this process remain poorly understood. Using RNA pull-down assays combined with mass spectrometry screening, we discovered five host proteins interacting with -1 PRF RNA, including Stem Loop Binding Protein (SLBP). Our findings revealed that SLBP overexpression enhanced frameshifting and promoted viral replication. Moreover, the interaction between SLBP and -1 PRF RNA was predicted using the PrismNet deep learning tool, which calculated a high binding probability of 0.922. Using Electrophoretic Mobility Shift Assays (EMSAs) and RNA pull down assays, our findings demonstrated SLBP's direct binding to the SARS-CoV-2 genome, with preferential affinity for the stem loop 3 region of the -1 PRF RNA. Using smFISH assays, we further confirmed their physical colocalization. The role of SLBP in promoting frameshifting was verified using an in vitro translation system. Further investigation showed that SLBP deletions reshaped the host factor pattern around -1 PRF RNA, diminishing interactions with FUBP3 and RPS3A while enhancing RPL10A binding. Together, our findings identify SLBP as a host protein that promotes SARS-CoV-2 frameshifting, highlighting its potential as a druggable target for COVID-19.

Authors

  • Tanxiu Chen
    State Key Laboratory of Respiratory Health and Multimorbidity, National Center of Technology Innovation for Animal Model, Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Institute of Laboratory Animal Science, CAMS & PUMC, Beijing, China.
  • Ruimin Zhu
    State Key Laboratory of Respiratory Health and Multimorbidity, National Center of Technology Innovation for Animal Model, Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Institute of Laboratory Animal Science, CAMS & PUMC, Beijing, China.
  • Tingfu Du
    Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
  • Hao Yang
    College of Agricultural Science and Engineering, Hohai University, Nanjing 210098, China.
  • Xintian Zhang
    Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
  • Zhixing Wang
    Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Yong Zhang
    Outpatient Department of Hepatitis, The Sixth Affiliated People's Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Wenqi Quan
    Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
  • Bin Yin
    Poultry Institute, Shandong Academy of Agricultural Science, Jinan, Shandong, China.
  • Yunpeng Liu
    e Faculty of Electronics & Computer , Zhejiang Wanli University , Ningbo , 315000 , China.
  • Shuaiyao Lu
    Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China. lushuaiyao-km@163.com.
  • Xiaozhong Peng
    State Key Laboratory of Respiratory Health and Multimorbidity, National Center of Technology Innovation for Animal Model, Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Institute of Laboratory Animal Science, CAMS & PUMC, Beijing, China. pengxiaozhong@pumc.edu.cn.